Skip to main content
CriticalFDAfda-F-0136-2025E COLI

raw, yellow onions (whole unpeeled), intended for food service, in 50-lb corrugated boxes

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (e coli). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
1,651
Recall Date
October 22, 2024
Issuing Agency
Hazard
E Coli

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0136-2025.

Potential contamination of E. coli O157:H7

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0136-2025.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Taylor Farms Colorado, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0136-2025.

Taylor Farms Colorado, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Taylor Farms Colorado, Inc. Recall FAQ

Taylor Farms Colorado, Inc. is the subject of a produce safety report: raw, yellow onions (whole unpeeled), intended for food service, in 50-lb corrugated boxes. The notice was published on October 22, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 1,651 units are potentially affected.